Published in Lancet Neurol on March 26, 2015
A Novel Missense Variant in the AGRN Gene; Congenital Myasthenic Syndrome Presenting With Head Drop. J Clin Neuromuscul Dis (2017) 0.81
Copy number analysis reveals a novel multiexon deletion of the COLQ gene in congenital myasthenia. Neurol Genet (2016) 0.79
A Missense Mutation in Epsilon-subunit of Acetylcholine Receptor Causing Autosomal Dominant Slow-channel Congenital Myasthenic Syndrome in a Chinese Family. Chin Med J (Engl) (2016) 0.75
Data transformations for improved display and fitting of single-channel dwell time histograms. Biophys J (1987) 9.64
Activation of acetylcholine receptors on clonal mammalian BC3H-1 cells by low concentrations of agonist. J Physiol (1986) 3.76
Duchenne dystrophy: electron microscopic findings pointing to a basic or early abnormality in the plasma membrane of the muscle fiber. Neurology (1975) 2.89
Agonists block currents through acetylcholine receptor channels. Biophys J (1984) 2.81
Monoclonal antibody analysis of mononuclear cells in myopathies. I: Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells. Ann Neurol (1984) 2.66
Activation of a nicotinic acetylcholine receptor. Biophys J (1984) 2.57
Mutation of the acetylcholine receptor alpha subunit causes a slow-channel myasthenic syndrome by enhancing agonist binding affinity. Neuron (1995) 2.55
Microvascular changes in early and advanced dermatomyositis: a quantitative study. Ann Neurol (1990) 2.42
Carnitine deficiency of human skeletal muscle with associated lipid storage myopathy: a new syndrome. Science (1973) 2.34
Fingerprint body myopathy, a newly recognized congenital muscle disease. Mayo Clin Proc (1972) 2.34
Congenital myasthenic syndrome caused by decreased agonist binding affinity due to a mutation in the acetylcholine receptor epsilon subunit. Neuron (1996) 2.27
Mutation in the M1 domain of the acetylcholine receptor alpha subunit decreases the rate of agonist dissociation. J Gen Physiol (1997) 2.25
Dihydropyridine receptor mutations cause hypokalemic periodic paralysis. Cell (1994) 2.15
The clinical spectrum of the eosinophilia-myalgia syndrome associated with L-tryptophan ingestion. Clinical features in 20 patients and aspects of pathophysiology. Ann Intern Med (1990) 2.06
Relationship between reversible antagonist occupancy and the functional capacity of the acetylcholine receptor. J Biol Chem (1981) 2.05
The relationship between agonist occupation and the permeability response of the cholinergic receptor revealed by bound cobra alpha-toxin. J Biol Chem (1980) 2.02
Polymyositis mediated by T lymphocytes that express the gamma/delta receptor. N Engl J Med (1991) 2.00
Congenital myasthenic syndrome caused by prolonged acetylcholine receptor channel openings due to a mutation in the M2 domain of the epsilon subunit. Proc Natl Acad Sci U S A (1995) 1.92
Choline acetyltransferase mutations cause myasthenic syndrome associated with episodic apnea in humans. Proc Natl Acad Sci U S A (2001) 1.90
Major histocompatibility complex class I antigen expression, immunolocalization of interferon subtypes, and T cell-mediated cytotoxicity in myopathies. Hum Pathol (1989) 1.89
Human endplate acetylcholinesterase deficiency caused by mutations in the collagen-like tail subunit (ColQ) of the asymmetric enzyme. Proc Natl Acad Sci U S A (1998) 1.85
Immune complexes (IgG and C3) at the motor end-plate in myasthenia gravis: ultrastructural and light microscopic localization and electrophysiologic correlations. Mayo Clin Proc (1977) 1.85
The immunobiology of muscle. Immunol Today (1994) 1.83
Muscle coenzyme Q deficiency in familial mitochondrial encephalomyopathy. Proc Natl Acad Sci U S A (1989) 1.82
Inclusion body myositis. Observations in 40 patients. Brain (1989) 1.82
Acetylcholinesterase of human erythrocytes and neuromuscular junctions: homologies revealed by monoclonal antibodies. Proc Natl Acad Sci U S A (1982) 1.79
Ultrastructural localization of the acetylcholine receptor in myasthenia gravis and in its experimental autoimmune model. Neurology (1977) 1.78
AlphaB-crystallin immunolocalization yields new insights into inclusion body myositis. Neurology (2000) 1.77
Anti-MuSK autoantibodies block binding of collagen Q to MuSK. Neurology (2011) 1.77
Myasthenia gravis and myasthenic syndromes. Ann Neurol (1984) 1.77
The extracellular linker of muscle acetylcholine receptor channels is a gating control element. J Gen Physiol (2000) 1.74
Structural basis of the different gating kinetics of fetal and adult acetylcholine receptors. Neuron (1994) 1.72
Acid maltase deficiency in adults: studies in four cases of a syndrome which may mimic muscular dystrophy or other myopathies. Brain (1970) 1.72
The spectrum and diagnosis of acid maltase deficiency. Neurology (1973) 1.71
Passive transfer of Lambert-Eaton myasthenic syndrome with IgG from man to mouse depletes the presynaptic membrane active zones. Proc Natl Acad Sci U S A (1983) 1.71
Serum choline activates mutant acetylcholine receptors that cause slow channel congenital myasthenic syndromes. Proc Natl Acad Sci U S A (1999) 1.68
Intracellular calcium accumulation in Duchenne dystrophy and other myopathies: a study of 567,000 muscle fibers in 114 biopsies. Neurology (1978) 1.63
Histometric analysis of the ultrastructure of the neuromuscular junction in myasthenia gravis and in the myasthenic syndrome. Ann N Y Acad Sci (1971) 1.62
New mutations in acetylcholine receptor subunit genes reveal heterogeneity in the slow-channel congenital myasthenic syndrome. Hum Mol Genet (1996) 1.60
Slow-channel myasthenic syndrome caused by enhanced activation, desensitization, and agonist binding affinity attributable to mutation in the M2 domain of the acetylcholine receptor alpha subunit. J Neurosci (1997) 1.59
Acetylcholine receptor activation by a site-selective ligand: nature of brief open and closed states in BC3H-1 cells. J Physiol (1986) 1.59
Multicore disease. A recently recognized congenital myopathy associated with multifocal degeneration of muscle fibers. Mayo Clin Proc (1971) 1.56
Failure of inactivation of Duchenne dystrophy X-chromosome in one of female identical twins. Neurology (1977) 1.53
Pathological mechanisms in experimental autoimmune myasthenia gravis. II. Passive transfer of experimental autoimmune myasthenia gravis in rats with anti-acetylcholine recepotr antibodies. J Exp Med (1976) 1.53
A newly recognized congenital myasthenic syndrome attributed to a prolonged open time of the acetylcholine-induced ion channel. Ann Neurol (1982) 1.52
Congenital myasthenic syndrome caused by a mutation in the Ets-binding site of the promoter region of the acetylcholine receptor epsilon subunit gene. Neuromuscul Disord (1999) 1.52
Aberrant splicing in adult onset glycogen storage disease type II (GSDII): molecular identification of an IVS1 (-13T-->G) mutation in a majority of patients and a novel IVS10 (+1GT-->CT) mutation. Hum Mol Genet (1994) 1.49
Zaspopathy in a large classic late-onset distal myopathy family. Brain (2007) 1.47
Congenital myasthenic syndromes due to heteroallelic nonsense/missense mutations in the acetylcholine receptor epsilon subunit gene: identification and functional characterization of six new mutations. Hum Mol Genet (1997) 1.45
Necrotizing myopathy with pipestem capillaries, microvascular deposition of the complement membrane attack complex (MAC), and minimal cellular infiltration. Neurology (1991) 1.45
Monoclonal antibody analysis of mononuclear cells in myopathies. II: Phenotypes of autoinvasive cells in polymyositis and inclusion body myositis. Ann Neurol (1984) 1.43
Acetylcholine receptor M3 domain: stereochemical and volume contributions to channel gating. Nat Neurosci (1999) 1.42
Analysis of cytokine expression in muscle in inflammatory myopathies, Duchenne dystrophy, and non-weak controls. J Neuroimmunol (1995) 1.42
The syndrome of systemic carnitine deficiency. Clinical, morphologic, biochemical, and pathophysiologic features. Neurology (1975) 1.38
A new myasthenic syndrome with end-plate acetylcholinesterase deficiency, small nerve terminals, and reduced acetylcholine release. Ann Neurol (1977) 1.36
Ultrastructural localization of the terminal and lytic ninth complement component (C9) at the motor end-plate in myasthenia gravis. J Neuropathol Exp Neurol (1980) 1.35
Autophagic glycogenosis of late onset with mitochondrial abnormalities: light and electron microscopic observations. Mayo Clin Proc (1968) 1.33
Experimental chloroquine myopathy. J Neuropathol Exp Neurol (1970) 1.30
Carnitine metabolism and inborn errors. J Inherit Metab Dis (1984) 1.30
The motor end plate in myasthenia gravis and in experimental autoimmune myasthenia gravis. A quantitative ultrastructural study. Ann N Y Acad Sci (1976) 1.30
Azathioprine with prednisone for polymyositis. A controlled, clinical trial. Ann Intern Med (1980) 1.29
The earliest pathologic alterations in dysferlinopathy. Neurology (2001) 1.28
Myofibrillar myopathy with abnormal foci of desmin positivity. I. Light and electron microscopy analysis of 10 cases. J Neuropathol Exp Neurol (1996) 1.27
Late-onset rod myopathy (a new syndrome?): light and electron microscopic observations in two cases. Mayo Clin Proc (1966) 1.25
Amyloid myopathy: an underdiagnosed entity. Ann Neurol (1998) 1.25
Coexistence in human and primate neuromuscular junctions of enzymes synthesizing acetylcholine, catecholamine, taurine, and gamma-aminobutyric acid. Proc Natl Acad Sci U S A (1982) 1.25
Complement activation in muscle fiber necrosis: demonstration of the membrane attack complex of complement in necrotic fibers. Ann Neurol (1982) 1.25
Histometric study of neuromuscular junction ultrastructure. I. Myasthenia gravis. Neurology (1972) 1.24
Retinocochleocerebral vasculopathy. Medicine (Baltimore) (1998) 1.23
Myofibrillar myopathy with abnormal foci of desmin positivity. II. Immunocytochemical analysis reveals accumulation of multiple other proteins. J Neuropathol Exp Neurol (1996) 1.22
Trophic functions of the neuron. II. Denervation and regulation of muscle. Morphological effects of denervation of muscle. A quantitative ultrastructural study. Ann N Y Acad Sci (1974) 1.22
Duchenne dystrophy. II. Morphometric study of motor end-plate fine structure. Brain (1974) 1.22
Local anesthetics and histrionicotoxin are allosteric inhibitors of the acetylcholine receptor. Studies of clonal muscle cells. J Biol Chem (1982) 1.21
Motor end-plate fine structure in acrylamide dying-back neuropathy: a sequential morphometric study. Neurology (1974) 1.21
Malignant hyperthermia testing in patients with persistently increased serum creatine kinase levels. Anesth Analg (1997) 1.19
Fundamental gating mechanism of nicotinic receptor channel revealed by mutation causing a congenital myasthenic syndrome. J Gen Physiol (2000) 1.18
Congenital endplate acetylcholinesterase deficiency responsive to ephedrine. Neurology (2005) 1.18
Mode switching kinetics produced by a naturally occurring mutation in the cytoplasmic loop of the human acetylcholine receptor epsilon subunit. Neuron (1998) 1.17
Congenital endplate acetylcholinesterase deficiency. Brain (1993) 1.16
Monoclonal antibody analysis of mononuclear cells in myopathies. III: Immunoelectron microscopy aspects of cell-mediated muscle fiber injury. Ann Neurol (1986) 1.16
Electron microscopic observations in thyrotoxic and corticosteroid-induced myopathies. Mayo Clin Proc (1966) 1.15
End-plate acetylcholine receptor deficiency due to nonsense mutations in the epsilon subunit. Ann Neurol (1996) 1.15
Hypoglycemia, hepatic dysfunction, muscle weakness, cardiomyopathy, free carnitine deficiency and long-chain acylcarnitine excess responsive to medium chain triglyceride diet. Pediatr Res (1983) 1.13
Carnitine metabolism and deficiency syndromes. Mayo Clin Proc (1983) 1.12
Acid maltase deficiency in adults presenting as respiratory failure. Am J Med (1978) 1.11
Regulatory properties of a mutant carnitine palmitoyltransferase in human skeletal muscle. Eur J Biochem (1985) 1.11
Observations on organization of Z-disk components and on rod-bodies of Z-disk origin. J Cell Biol (1971) 1.11
Normal and denervated muscle. A morphometric study of fine structure. Neurology (1973) 1.10
Structural elements in alpha-conotoxin ImI essential for binding to neuronal alpha7 receptors. J Biol Chem (1998) 1.10
Study of long-term anticholinesterase therapy. Effects on neuromuscular transmission and on motor end-plate fine structure. Neurology (1973) 1.10
Tissue distribution of carnitine biosynthetic enzymes in man. Biochim Biophys Acta (1980) 1.10